#TRLInsights - 94% of technology vendors list risk aversion as an implementation barrier for patient-facing technologies in clin
21 Aug 2023, 11:51
#TRLInsights - 94% of technology vendors list risk aversion as an implementation barrier for patient-facing technologies in clinical trials.
Early partnerships, customer engagement & experimentation were mentioned as key implementation enablers.
Source:
Same news in other sources
2
21 Aug 2023, 11:53
Triall Insights š
94% of technology vendors list risk aversion as a top implementation barrier for patient-facing digital technologies in clinical trials.
Early partnerships, decision-maker engagement, and rapid experimentation were mentioned as key ways to overcome implementation barriers.
Source: transceleratebiopharmainc.com/assets/patient-technology-implementation-framework/patient-technology-assets/
ā”ļø Trade $TRL at bit.ly/tradeTRL
š£ Help us spread the news on Twitter:
#blockchainforhealth #TRL
Triall Insights.
Triall Insights š
94% of technology vendors list risk aversion as a top implementation barrier for patient-facing digital technologies in clinical trials.
Early partnerships, decision-maker engagement, and rapid experimentation were mentioned as key ways to overcome implementation barriers.
Source: transceleratebiopharmainc.com/assets/patient-technology-implementation-framework/patient-technology-assets/
ā”ļø Trade $TRL at bit.ly/tradeTRL
š£ Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1693591725560729980?s=20
#blockchainforhealth #TRL
21 Aug 2023, 11:53
Triall Insights š
94% of technology vendors list risk aversion as a top implementation barrier for patient-facing digital technologies in clinical trials.
Early partnerships, decision-maker engagement, and rapid experimentation were mentioned as key ways to overcome implementation barriers.
Source: transceleratebiopharmainc.com/assets/patient-technology-implementation-framework/patient-technology-assets/
ā”ļø Trade $TRL at bit.ly/tradeTRL
š£ Help us spread the news on Twitter:
#blockchainforhealth #TRL
Triall Insights.
Triall Insights š
94% of technology vendors list risk aversion as a top implementation barrier for patient-facing digital technologies in clinical trials.
Early partnerships, decision-maker engagement, and rapid experimentation were mentioned as key ways to overcome implementation barriers.
Source: transceleratebiopharmainc.com/assets/patient-technology-implementation-framework/patient-technology-assets/
ā”ļø Trade $TRL at bit.ly/tradeTRL
š£ Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1693591725560729980?s=20
#blockchainforhealth #TRL